Durvalumab (D) plus tremelimumab (T) for the treatment of patients with progressive, refractory advanced thyroid carcinoma: The DUTHY (GETNE-T1812) trial


Por: Castillon J, Plana M, Castelo B, Iglesias L, Hernando J, Tur R, Baste N, Carmona-Bayonas A, Ruiz S, Trigo J, Lorenzo-Lorenzo I, Grande E, Lorente D, Ugidos L, Marquina G, Garcia-Alvarez A, Taberna M, Villamayor J, Molina-Cerrillo J, Alonso-Gordoa T

Publicada: 1 sep 2022 Ahead of Print: 1 sep 2022
Resumen:

ISSN: 09237534





Annals Of Oncology
Editorial
OXFORD UNIV PRESS, GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND, Reino Unido
Tipo de documento: Article
Volumen: 33 Número: 7
Páginas: 1294-1295
WOS Id: 000866211602197

MÉTRICAS